Showing results (71-80 of 1,944) with videos related to

Sort By:
Pageof 195
RMD Open|February 11, 2021
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experiencedChristopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, et al.
RMD Open|August 16, 2019
Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound scoreSøren Andreas Just, Christian Nielsen, Jens Christian Werlinrud, et al.
RMD Open|August 16, 2019
Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligibleOlafur Palsson, Thorvardur Jon Love, Anna Ingibjorg Gunnarsdottir, et al.
RMD Open|April 4, 2025
Long-term evolution of postpartum sacroiliac bone marrow oedema: a 5-year longitudinal follow-up studyGaëlle Varkas, Liesbet De Meester, Manouk de Hooge, et al.
RMD Open|April 24, 2025
Mitochondrial dysfunction and fatigue in Sjögren's diseaseBiji T Kurien, John Aubrey Ice, Rebecca A Wood, et al.
RMD Open|April 18, 2025
Myocardial infarction in ANCA-associated vasculitis: a population-based cohort studyYlva Borgas, Moman Aladdin Mohammad, Karl Gisslander, et al.
RMD Open|March 28, 2025
Social media in advancing equity and collaboration in rheumatology: the CORDIALITY reviewIhsane Hmamouchi, Nelly Ziade, Adewale Adebajo, et al.
RMD Open|June 6, 2025
Predictors of persistent active disease and the longitudinal development of organ damage, patient-reported outcomes and autoantibodies in long-term juvenile dermatomyositisSimon Girmai Girmai Berger, Kristin Schjander Berntsen, Kristine Risum, et al.
RMD Open|June 13, 2025
Rising incidence of systemic autoimmune inflammatory rheumatic diseases during the COVID-19 pandemic: a geographical cohort studyEnrico De Lorenzis, Paolo Parente, Salvatore Soldati, et al.
RMD Open|May 9, 2025
Elevated serum levels of interleukin-18 discriminate Still's disease from other autoinflammatory conditions: results from the European ImmunAID cohortCharlotte Girard-Guyonvarc'h, Emiliana Rodriguez, Yvonne M Mueller, et al.
Pageof 195